Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|May 31, 2019
Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in ChinaXingyun Hou, Xu Wan, Bin Wu
Diabetes, Obesity & Metabolism|November 30, 2023
Ethnic disparities in cardiovascular and renal responses to canagliflozin between Asian and White patients with type 2 diabetes mellitus: A post hoc analysis of the CANVAS ProgramXi Chen, Xingyun Hou, Junling Gao, et al.
Frontiers in Oncology|March 20, 2026
The role of L3 skeletal muscle index in the diagnosis and prognosis prediction of sarcopenia and malnutrition in cancer patientsZhuo Chen, Deduo Xu, Xingyun Hou, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 30, 2025
Discovery of a predictive model for anlotinib-induced hand-foot syndrome based on metabolomicsJuanjuan Hou, Mao Tang, Xingyun Hou, et al.
International Journal of Cardiology. Heart & Vasculature|April 21, 2025
Metabolic dysfunction-associated steatotic liver disease and increased risk of atrial fibrillation in the elderly: A longitudinal cohort studyYehua Tang, Jianling Fan, Xingyun Hou, et al.
BMC Geriatrics|May 7, 2026
Vancomycin-induced acute kidney injury in older Chinese patients: a multicenter retrospective cohort studyYing Zhang, Yuzhu Wang, Sunhui Zhou, et al.
Microbiology Spectrum|July 6, 2026
Risk of acute kidney injury in patients on concomitant vancomycin and piperacillin-tazobactam compared to vancomycin and other beta-lactam agents: a large multicenter retrospective cohort study from ChinaKunming Pan, Xingyun Hou, Jie Li, et al.
Frontiers in Endocrinology|September 19, 2024
Metabolic-associated steatotic liver disease and risk of Alzheimer's disease: a real-world retrospective cohort studyJiaqi Zhang, Wenzhao Wang, Xingyun Hou, et al.
Infection and Drug Resistance|July 27, 2026
Risk Stratification for Vancomycin-Associated Acute Kidney Injury in Chinese Adult Inpatients: A Multicenter Retrospective Cohort StudyShu Chen, Ying Zhang, Xingyun Hou, et al.
Basic & Clinical Pharmacology & Toxicology|February 23, 2019
Wuzhi capsule regulates chloroacetaldehyde pharmacokinetics behaviour and alleviates high-dose cyclophosphamide-induced nephrotoxicity and neurotoxicity in ratsLi Chen, Xiaojuan Xiong, Xingyun Hou, et al.
Pageof 2